Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptanKen Ohara, Daisuke Nagata, Takahiro Masuda et al.|Nephrology|2018Cited by 82
Common risk variants in NPHS1 and TNFSF15 are associated with childhood steroid-sensitive nephrotic syndromeXiaoyuan Jia, Yuji Kano, Tomoko Horinouchi et al.|Kidney International|2020Cited by 74
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Daisuke Nagata, Takahiro Masuda et al.|Diabetology & Metabolic Syndrome|2020Cited by 66
Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by HyponatremiaTakuya Murakami, Daisuke Nagata, Tetsu Akimoto et al.|Drug Target Insights|2018Cited by 9
Comparative Impact of Isolated Ultrafiltration and Hemodialysis on Fluid Distribution: A Bioimpedance StudyYuki Akiyama, Daisuke Nagata, Ryo Matsuoka et al.|Blood Purification|2021Cited by 4